in fact, the report notes that direct health systems costs of vision loss are more than those of all cancers, respiratory disorders and endocrine diseases like diabetes.
as the deloitte report adds, “at the individual level, people living with vision loss are impacted financially due to fewer job opportunities, increased absences from work, and reduced productivity at work when they are not fully supported in their roles. the cost of vision loss also extends beyond those living with vision loss, to family, friends, and caregivers, as they provide care for a person living with vision loss. at the economic level, inefficiencies arise from government welfare transfers and financing of services (such as hospitals), which impose losses on society.”
in 2019, deloitte found that other financial and economic costs were estimated at $1.8 billion, including low vision rehabilitation services ($84.9 million) and the cost of vision aids, assistive technology and home modifications ($166.4 million). these devices and home renovations are important for people to age in place and maintain independence.
in addition, the cost of formal care for those with vision loss was about $336.6 million and the cost of aged and home care was $446.8 million, while economic efficiency losses were estimated at $769 million. almost half the other costs are borne by society as a whole (47.4 per cent) while governments bear 27.2 per cent, individuals bear 24.5 per cent, and family and friends bear 0.9 per cent.